Back to ProShare Advisors LLC ProShare Advisors LLC

CHRSCHRS
Showing 8 of 31 quarters

Position history for ProShare Advisors LLCProShare Advisors LLC's holdings in COHERUS ONCOLOGY INC

ProShare Advisors LLC holds 22,172 shares of CHRS (COHERUS ONCOLOGY INC), worth $31,040 as of 2026-Q2. The position was increased (+2.2% shares).

Current Value

$31,040

Current Shares

22,172

Total Value Change

+$2,095

Total Shares Change

-5,659

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
22,172
+2.2%
$31,0400.0%$1.40
14
2026-Q1
Decreased
21,700
-12.2%
$36,6740.0%$1.65
0
2025-Q4
Increased
24,718
+36.3%
$35,0990.0%$1.41
26
2025-Q3
Decreased
18,135
-16.6%
$29,7410.0%$1.70
0
2025-Q2
Decreased
21,748
-10.6%
$15,9040.0%$0.74
0
2025-Q1
Decreased
24,331
-22.4%
$19,6350.0%$0.84
0
2024-Q4
Increased
31,335
+12.6%
$43,2420.0%$1.50
23
2024-Q3
Increased
27,831
+31.6%
$28,9450.0%$1.05
25

Other major holders of CHRS: BNP PARIBAS FINANCIAL MARKETS, Temasek Holdings (Private) Ltd

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used